Interferon gamma therapy for cutaneous leishmaniasis.
Kürkçüoğlu
N
N
Tandoğdu
R
R
D000818:Animals; D000965:Antimony / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use*; D007895:Leishmania tropica; D007896:Leishmaniasis / Q000188:drug therapy / Q000628:therapy*; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use; D011994:Recombinant Proteins
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D011994:Recombinant Proteins; D008536:Meglumine; D000077485:Meglumine Antimoniate; D007371:Interferon-gamma; D000965:Antimony